20250177394. Combinations Ctps1 B (Step Pharma S.A.S.): Difference between revisions
Wikipatents (talk | contribs) Automated patent report |
Wikipatents (talk | contribs) Automated patent report |
||
| Line 21: | Line 21: | ||
<!-- JSON-LD markup for search engines: | <!-- JSON-LD markup for search engines: | ||
{"@context":"https://schema.org","@type":"TechArticle","headline":"20250177394. Combinations Ctps1 B (Step Pharma S.A.S.)","name":"20250177394. Combinations Ctps1 B (Step Pharma S.A.S.)","description":"Patent application abstract and classification for 20250177394 - Combinations Of Ctps1 And B","datePublished":"2025-06- | {"@context":"https://schema.org","@type":"TechArticle","headline":"20250177394. Combinations Ctps1 B (Step Pharma S.A.S.)","name":"20250177394. Combinations Ctps1 B (Step Pharma S.A.S.)","description":"Patent application abstract and classification for 20250177394 - Combinations Of Ctps1 And B","datePublished":"2025-06-11","mainEntity":{"@type":"GovernmentPermit","permitType":"Patent Application","identifier":"20250177394","name":"Combinations Of Ctps1 And B","additionalProperty":[{"@type":"PropertyValue","name":"Organization","value":"Step Pharma S.A.S."}]}} | ||
--> | --> | ||
Latest revision as of 03:36, 11 June 2025
COMBINATIONS OF CTPS1 AND BCL2 INHIBITORS FOR CANCER
Abstract: the invention provides inter alia methods of treating cancer comprising administering to a subject a cytidine triphosphate synthase 1 (ctps1) inhibitor and a b-cell lymphoma 2 (bcl2) inhibitor.
Inventor(s): Philip BEER, David CHIRON, Andrew PARKER, Catherine PELLAT-DECEUNYNCK
CPC Classification: A61K31/506 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms ; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles ; soap compositions ))
Search for rejections for patent application number 20250177394